Welcome to the eilslabs

The eilslabs form a joint research group between the division "Theoretical Bioinformatics" at the German Cancer Research Center (dkfz) and the department Bioinformatics and Functional Genomics at the Institute of Pharmacy and Molecular Biotechnology (IPMB) at Heidelberg University. The group is headed by Prof. Roland Eils.

 


Together with colleagues from the Center of Health Economics Research in Hannover, Roland Eils has published a study on the economic impact of genome sequencing in clinical practice. The study by Frank et al. critically assesses genome sequencing literature in order to elucidate the real healthcare costs of genome sequencing. The authors conclude that current health economic evidence for genome sequencing is quite poor and lists specific aspects to be considered.
Overall the authors come to the conclusion that it is still a long way to achieve the $ 1000 genome and if all costs are considered it seems unlikely that it will be ever achieved.

Citation:

  • Frank, M., Prenzler, A., Eils, R., and Graf von der Schulenburg, J.-M. (2013). Genome sequencing: a systematic review of health economic evidence. Health Economics Review 3, 29. doi: 10.1186/2191-1991-3-29